
|Videos|November 7, 2017
Dr. Mikhail on Ongoing Clinical Trials for Patients With Myeloma
Author(s)Sameh Mikhail, MD
Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discusses ongoing clinical trials for patients with myeloma.
Advertisement
Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discusses ongoing clinical trials for patients with myeloma.
Current studies are looking at stem cell transplants in patients with myeloma. There are a lot of immunomodulatory agents and combinations being looked at, says Mikhail.
Immunotherapy for patients with multiple myeloma is also being scrutinized for its safety concerns, but it appears to show encouraging results in other settings, explains Mikhail.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5



































